There is an unmet need for therapies targeting Duchenne muscular dystrophy (DMD)–related heart disease, and phase 2 results ...

Medera, Inc., ("Medera”), a clinical-stage biotechnology company, announced today that the management team will partic ...

Heart failure remains a substantial burden for patients due to its high prevalence and limited therapeutic options. Heart ...

Heart failure remains a substantial burden for patients due to its high prevalence and limited therapeutic options. Heart failure is classified into two major clinical subtypes- heart failure with ...

Eko Health has been advancing the use of artificial intelligence to help providers detect the early signs of disease, ...

How would you summarize your study for a lay audience?Heart failure remains a substantial burden for patients due to its high ...

Patients with rheumatoid arthritis are associated with an increased risk for heart failure, particularly heart failure with preserved ejection fraction.

Drinking ketones improves heart health, a new small-scale study from the University of Portsmouth has found. This is the first time people with type 2 diabetes (T2D) have been given a drink with ...

Danielle Rasooly, PhD, of the Division of Aging at Brigham and Women’s Hospital, is the co-corresponding author of a paper published in Nature Cardiovascular Research, “Large-scale multi-omics ...

Interested parties may access the live webcast of the fireside chat by visiting the Investors & Media section of the Cytokinetics website at https://www.cytokinetics.com. The webcast replay will be ...

Tectonic Therapeutic has done well to advance its Fc-fusion protein candidate TX45 into a phase 2 study targeting patients ...

Berlin: Bayer has announced the submission of a marketing authorization application to the European Medicines Agency (EMA), ...